Back

Smokeless tobacco, snus, at admission for percutaneous coronary intervention and future risk of death

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation Revascularisation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Pontus Andell

Karolinska University Hospital, Stockholm (Sweden)

16 More presentations in this session

Presentation thumbnail
Fibrinolytic therapy in patients with ST-segment elevation myocardial infarction: Accelerated versus standard Streptokinase infusion regimen; a randomized clinical study
Associate Professor A. Bendary (Benha, EG)
Abstract Slides
Presentation thumbnail
Heart rate reduction with ivabradine restores endothelial function and reduces vascular stiffness in patients with chronic stable coronary artery disease
Doctor A. Hohneck (Mannheim, DE)
Abstract Slides
Presentation thumbnail
Comparative efficacy of angiotensin converting enzyme inhibitor and angiotensin receptor blocker for patients with acute myocardial infarction and renal dysfunction
Doctor J. Won (Gwangju, KR)
Abstract
Presentation thumbnail
Therapeutic advantages of long-acting trimetazidine for the treatment of stable angina pectoris in routine clinical practice: findings from ODA trial
Professor M. Glezer (Moscow, RU)
Abstract
Presentation thumbnail
Mid-term outcomes of second-generation drug-eluting-stent implantation for left main coronary artery disease compare with first-generation drug-eluting-stent
Doctor G. Yoshioka (Saga, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 7 - Coronary artery disease - Diagnosis, pharmacotherapy and revascularisation

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources